相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Genomic Alteration-Driven Clinical Trial Designs in Oncology
Richard Simon
ANNALS OF INTERNAL MEDICINE (2016)
The BATTLE-2 Study: A Biomarker-Integrated Targeted Therapy Study in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer
Vassiliki Papadimitrakopoulou et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial
Nicholas D. James et al.
LANCET (2016)
Adaptive Randomization of Neratinib in Early Breast Cancer
J. W. Park et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Statistical controversies in clinical research: scientific and ethical problems with adaptive randomization in comparative clinical trials
P. Thall et al.
ANNALS OF ONCOLOGY (2015)
Lung Master Protocol (Lung-MAP)-A Biomarker-Driven Protocol for Accelerating Development of Therapies for Squamous Cell Lung Cancer: SWOG S1400
Roy S. Herbst et al.
CLINICAL CANCER RESEARCH (2015)
Are outcome-adaptive allocation trials ethical? Commentary
J. Jack Lee
CLINICAL TRIALS (2015)
Are outcome-adaptive allocation trials ethical? Commentary
Scott Brian Saxman
CLINICAL TRIALS (2015)
Are outcome-adaptive allocation trials ethical? Commentary
Steven Joffe et al.
CLINICAL TRIALS (2015)
Are outcome-adaptive allocation trials ethical? Commentary
Marc Buyse
CLINICAL TRIALS (2015)
Commentary on Hey and Kimmelman
Edward L Korn et al.
Clinical Trials (2015)
Rejoinder
Spencer Phillips Hey et al.
CLINICAL TRIALS (2015)
Are outcome-adaptive allocation trials ethical? Commentary
Donald A. Berry
CLINICAL TRIALS (2015)
Are outcome-adaptive allocation trials ethical?
Spencer Phillips Hey et al.
CLINICAL TRIALS (2015)
Marker Sequential Test (MaST) design
Boris Freidlin et al.
CLINICAL TRIALS (2014)
When is a seamless study desirable? Case studies from different pharmaceutical sponsors
Robert L. Cuffe et al.
PHARMACEUTICAL STATISTICS (2014)
Molecular Analysis for Therapy Choice: NCI MATCHd
Barbara A. Conley et al.
SEMINARS IN ONCOLOGY (2014)
Evaluating Many Treatments and Biomarkers in Oncology: A New Design
Richard Kaplan et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Design Issues in Randomized Phase II/III Trials
Edward L. Korn et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Randomized Phase II Trial Designs With Biomarkers
Boris Freidlin et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Bayesian clinical trials in action
J. Jack Lee et al.
STATISTICS IN MEDICINE (2012)
Outcome-Adaptive Randomization: Is It Useful?
Edward L. Korn et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Using randomization tests to preserve type I error with response adaptive and covariate adaptive randomization
Richard Simon et al.
STATISTICS & PROBABILITY LETTERS (2011)
The BATTLE Trial: Personalizing Therapy for Lung Cancer
Edward S. Kim et al.
CANCER DISCOVERY (2011)
Biostatistical Considerations in Development of Biomarker-Based Tests to Guide Treatment Decisions
Gary M. Clark et al.
STATISTICS IN BIOPHARMACEUTICAL RESEARCH (2011)
A general inefficacy interim monitoring rule for randomized clinical trials
Boris Freidlin et al.
CLINICAL TRIALS (2010)
Randomized Clinical Trials With Biomarkers: Design Issues
Boris Freidlin et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
I-SPY 2: An Adaptive Breast Cancer Trial Design in the Setting of Neoadjuvant Chemotherapy
A. D. Barker et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Use of Archived Specimens in Evaluation of Prognostic and Predictive Biomarkers
Richard M. Simon et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
A randomized study of clofarabine versus clofarabine plus low-dose cytarabine as front-tine therapy for patients aged 60 years and older with acute myeloid leukemia and high-risk myelodysplastic syndrome
Stefan Faderl et al.
BLOOD (2008)
Multi-arm clinical trials of new agents: Some design considerations
Boris Freidlin et al.
CLINICAL CANCER RESEARCH (2008)
Confirmatory seamless phase II/III clinical trials with hypotheses selection at interim:: General concepts
Frank Bretz et al.
BIOMETRICAL JOURNAL (2006)
分享论文
